Biosig sees positive momentum from sales pipeline growth

Westport, ct, aug. 16, 2022 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) ("biosig" or the "company"), a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal processing platform, today announced that it is seeing positive momentum from the growth of its sales pipeline, and expects to see an increase in enterprise adoption of its pure ep™ system  in the coming months.
BSGM Ratings Summary
BSGM Quant Ranking